Post Marketing Surveillance on Long-term Use With Norditropin ® (Short Stature Due to Noonan Syndrome)
Conditions:   Genetic Disorder;   Noonan Syndrome Intervention:   Drug: Somatropin Sponsor:   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2018 Category: Research Source Type: clinical trials

Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome
Condition:   Noonan SyndromeInterventions:   Drug: Simvastatin;   Drug: PlaceboSponsor:   University Hospital, ToulouseNot yet recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2016 Category: Research Source Type: clinical trials